Refine
Year of publication
Has Fulltext
- yes (55)
Is part of the Bibliography
- no (55)
Keywords
- LHC (6)
- ALICE experiment (3)
- pp collisions (3)
- ALICE (2)
- Atmospheric chemistry (2)
- Beauty production (2)
- Single electrons (2)
- Atmospheric science (1)
- BCOR (1)
- CVID (1)
- Ceteris paribus laws (1)
- Climate change (1)
- Climate-change impacts (1)
- Comparison with QCD (1)
- Concept paper (1)
- Data protection (1)
- Datenschutz (1)
- European Society for Immunodeficiencies (ESID) (1)
- Ewing-like (1)
- Femtoscopy (1)
- German PID-NET registry (1)
- HBT (1)
- Hadron production (1)
- Heavy Ions (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- IgG substitution therapy (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Jets (1)
- Konzeptpapier (1)
- Ludwig Boltzmann (1)
- Max Weber (1)
- Mid-rapidity (1)
- Minutis rectis laws (1)
- Multi-strange baryons (1)
- Next-generation sequencing (1)
- Nuclear modification factor (1)
- PID prevalence (1)
- Pb–Pb (1)
- Physics (1)
- Proton–proton (1)
- RGAG1 (1)
- Rare diseases (1)
- Register (1)
- Registries (1)
- Sarcoma (1)
- Second Law of Thermodynamics (1)
- Seltene Erkrankungen (1)
- Single muons (1)
- Sociology (1)
- Thermodynamics (1)
- Typicality (1)
- binary nucleation (1)
- ion‐induced nucleation (1)
- primary immunodeficiency (PID) (1)
- registry for primary immunodeficiency (1)
- spectra (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (35)
- Frankfurt Institute for Advanced Studies (FIAS) (27)
- Informatik (27)
- Geowissenschaften (12)
- Medizin (6)
- Biochemie und Chemie (1)
- Gesellschaftswissenschaften (1)
- MPI für Hirnforschung (1)
Sulfuric acid is an important gas influencing atmospheric new particle formation (NPF). Both the binary (H2SO4–H2O) system and the ternary system involving ammonia (H2SO4–H2O–NH3) may be important in the free troposphere. An essential step in the nucleation of aerosol particles from gas-phase precursors is the formation of a dimer, so an understanding of the thermodynamics of dimer formation over a wide range of atmospheric conditions is essential to describe NPF. We have used the CLOUD chamber to conduct nucleation experiments for these systems at temperatures from 208 to 248 K. Neutral monomer and dimer concentrations of sulfuric acid were measured using a chemical ionization mass spectrometer (CIMS). From these measurements, dimer evaporation rates in the binary system were derived for temperatures of 208 and 223 K. We compare these results to literature data from a previous study that was conducted at higher temperatures but is in good agreement with the present study. For the ternary system the formation of H2SO4·NH3 is very likely an essential step in the formation of sulfuric acid dimers, which were measured at 210, 223, and 248 K. We estimate the thermodynamic properties (dH and dS) of the H2SO4·NH3 cluster using a simple heuristic model and the measured data. Furthermore, we report the first measurements of large neutral sulfuric acid clusters containing as many as 10 sulfuric acid molecules for the binary system using chemical ionization–atmospheric pressure interface time-of-flight (CI-APi-TOF) mass spectrometry.
Snapshots of acetyl-CoA synthesis, the final step of CO₂ fixation in the Wood-Ljungdahl pathway
(2024)
In the ancient microbial Wood-Ljungdahl pathway, CO2 is fixed in a multi-step process with acetyl-CoA synthesis at the bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase complex (CODH/ACS). Here, we present catalytic snapshots of the CODH/ACS from the gas-converting acetogen Clostridium autoethanogenum, characterizing the molecular choreography of the overall reaction including electron transfer to the CODH for CO2 reduction, methyl transfer from the corrinoid iron-sulfur protein (CoFeSP) partner to the ACS active site and acetyl-CoA production. Unlike CODH, the multidomain ACS undergoes large conformational changes to form an internal connection to the CODH active site, accommodate the CoFeSP for methyl transfer and protect the reaction intermediates. Altogether, the structures allow us to draw a detailed reaction mechanism of this enzyme crucial for CO2 fixation in anaerobic organisms.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.